Market Overview:
The global human genetics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of genetic disorders, rising demand for personalized medicine, and technological advancements in human genetics. Based on type, the cytogenetics segment is expected to account for the largest share of the global human genetics market in 2018. This segment is mainly driven by the increasing use of cytogenetics in prenatal diagnosis and cancer diagnosis. Based on application, research centers are expected to account for the largest share of the global human genetics market in 2018. This segment is mainly driven by rising demand for genetic testing services for research purposes. Geographically, North America accounted for the largest share of the global human genetics market in 2017 and this trend is projected to continue during forecast period owing to high adoption rate of advanced technologies.
Product Definition:
Human genetics is the study of genes and their effects on human characteristics. It can be used to determine a person's risk for developing certain diseases, to identify genetic disorders, and to evaluate the success of treatments for genetic disorders. Human genetics is also used in paternity testing and in genealogy research.
Cytogenetics:
Cytogenetics is the study of cell biology and genetics using methods such as microscopic techniques, biochemical analysis, and genetic probes. It mainly deals with the structure and behavior of genes in their physiological environment. Cytogenetic techniques have applications in human disease diagnosis & research as well as in vitro fertilization (IVF). IVF can be used to treat some genetic diseases that are passed on from parents to child.
Prenatal Genetics:
Prenatal genetics is the study of genetic variations that take place during prenatal period. It includes detection and screening of chromosomal anomalies in the fetus, determination of sex, and analysis of genetic diseases occurring in pregnancy. Prenatal diagnosis (PD) has been used for decades to diagnose congenital abnormalities in infants with no or minimal symptoms at birth.
Application Insights:
The research center application segment accounted for the largest revenue share of over 60% in 2017. The growth is attributed to an increase in R&D activities pertaining to inheritance disorders, genetic diseases and chromosomal aberrations at a global level. A large number of research projects are being carried out with the participation of private institutions and organizations across the world. For instance, International HapMap Project was a collaborative effort among National Cancer Institute (NCI), University of California (UCSF), Wellcome Trust Sanger Centre, and Department of Energy (DOE) which aimed at studying human genealogy by mapping common variation across worldwide populations. Such initiatives are expected to boost market growth over the forecast period.
Regional Analysis:
North America dominated the global human genetics market in 2017. This can be attributed to the presence of a large number of genetic testing providers, advanced healthcare system and reimbursement policies, and increasing R&D investments by pharmaceutical companies. Moreover, growing population with high disposable income is expected to drive demand for diagnostic services over the forecast period.
Asia Pacific is estimated to grow at a lucrative rate during the forecast period owing to an increase in government initiatives for early diagnosis coupled with rising awareness about available treatment options among patients. For instance, according to data published by National Health & Family Planning Commission (NHFPC) of China in 2016 around 1 million people were diagnosed annually through prenatal screening programs conducted in China from 2011 till 2015 resulting into an increased rate of congenital disorders over this time span as compared to previous decade(1999-2011).
Growth Factors:
- Increasing incidence of genetic disorders and birth defects: The increasing incidence of genetic disorders and birth defects is one of the key growth drivers for the human genetics market. This is because human genetics helps in diagnosing, treating, and managing these conditions.
- Rising demand for personalized medicine: The rising demand for personalized medicine is another key growth driver for the human genetics market. This is because human genetics helps in tailoring treatments according to an individual’s specific needs and requirements.
- Advances in genomic sequencing technology: The advances in genomic sequencing technology are another key growth driver for the human genetics market. This is because this technology helps in decoding an individual’s genome quickly and accurately.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Genetics Market Research Report
By Type
Cytogenetics, Prenatal Genetics, Molecular Genetics, Symptom Genetics
By Application
Research Center, Hospital, Forensic Laboratories
By Companies
QIAGEN, Agilent Technologies, Thermo Fisher Scientific, Illumina, Promega, LabCorp, GE
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Human Genetics Market Report Segments:
The global Human Genetics market is segmented on the basis of:
Types
Cytogenetics, Prenatal Genetics, Molecular Genetics, Symptom Genetics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Center, Hospital, Forensic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- QIAGEN
- Agilent Technologies
- Thermo Fisher Scientific
- Illumina
- Promega
- LabCorp
- GE
Highlights of The Human Genetics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cytogenetics
- Prenatal Genetics
- Molecular Genetics
- Symptom Genetics
- By Application:
- Research Center
- Hospital
- Forensic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Genetics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human genetics is the study of the genetic makeup of humans. This includes studying how genes influence physical and behavioral traits, as well as diseases.
Some of the major players in the human genetics market are QIAGEN, Agilent Technologies, Thermo Fisher Scientific, Illumina, Promega, LabCorp, GE.
The human genetics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Genetics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Genetics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Genetics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Genetics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Genetics Market Size & Forecast, 2018-2028
4.5.1 Human Genetics Market Size and Y-o-Y Growth
4.5.2 Human Genetics Market Absolute $ Opportunity
Chapter 5 Global Human Genetics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human Genetics Market Size Forecast by Type
5.2.1 Cytogenetics
5.2.2 Prenatal Genetics
5.2.3 Molecular Genetics
5.2.4 Symptom Genetics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human Genetics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human Genetics Market Size Forecast by Applications
6.2.1 Research Center
6.2.2 Hospital
6.2.3 Forensic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Genetics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Genetics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human Genetics Analysis and Forecast
9.1 Introduction
9.2 North America Human Genetics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human Genetics Market Size Forecast by Type
9.6.1 Cytogenetics
9.6.2 Prenatal Genetics
9.6.3 Molecular Genetics
9.6.4 Symptom Genetics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human Genetics Market Size Forecast by Applications
9.10.1 Research Center
9.10.2 Hospital
9.10.3 Forensic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human Genetics Analysis and Forecast
10.1 Introduction
10.2 Europe Human Genetics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human Genetics Market Size Forecast by Type
10.6.1 Cytogenetics
10.6.2 Prenatal Genetics
10.6.3 Molecular Genetics
10.6.4 Symptom Genetics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human Genetics Market Size Forecast by Applications
10.10.1 Research Center
10.10.2 Hospital
10.10.3 Forensic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human Genetics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human Genetics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human Genetics Market Size Forecast by Type
11.6.1 Cytogenetics
11.6.2 Prenatal Genetics
11.6.3 Molecular Genetics
11.6.4 Symptom Genetics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human Genetics Market Size Forecast by Applications
11.10.1 Research Center
11.10.2 Hospital
11.10.3 Forensic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human Genetics Analysis and Forecast
12.1 Introduction
12.2 Latin America Human Genetics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human Genetics Market Size Forecast by Type
12.6.1 Cytogenetics
12.6.2 Prenatal Genetics
12.6.3 Molecular Genetics
12.6.4 Symptom Genetics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human Genetics Market Size Forecast by Applications
12.10.1 Research Center
12.10.2 Hospital
12.10.3 Forensic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human Genetics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human Genetics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human Genetics Market Size Forecast by Type
13.6.1 Cytogenetics
13.6.2 Prenatal Genetics
13.6.3 Molecular Genetics
13.6.4 Symptom Genetics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human Genetics Market Size Forecast by Applications
13.10.1 Research Center
13.10.2 Hospital
13.10.3 Forensic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Genetics Market: Competitive Dashboard
14.2 Global Human Genetics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 QIAGEN
14.3.2 Agilent Technologies
14.3.3 Thermo Fisher Scientific
14.3.4 Illumina
14.3.5 Promega
14.3.6 LabCorp
14.3.7 GE
